J.E. Díaz et al. / Journal of Molecular Structure 982 (2010) 50–56
51
N-(2-Bromophenyl)acetyl-N0-(2-nitrophenyl)-1,3-propanedi-
amine (3c) was obtained as a yellow solid (80%), Mp 125–127 °C
(ethanol/water). 1H NMR: d = 8.14 (1H, dd, J = 8.5 and 1.5 Hz),
8.03 (1H, bs, ex), 7.57 (1H, dd, J = 7.8 and 0.9 Hz), 7.12–7.43 (4H,
m), 6.78 (1H, d, J = 8.0 Hz), 6.63 (1H, ddd, J = 8.5, 7.1 and 1.3 Hz),
5.59 (1H, bs, ex), 3.72 (2H, s), 3.37 (2H, q, J = 6.4 Hz), 3.28–3.34
(2H, m), 1.86–1.90 (2H, m). MS (EI), m/z 391 (M+.). Anal. Calcd.
for C17H18BrN3O3: C, 52.06; H, 4.63; N, 10.71, found: C, 51.98; H,
4.68; N, 10.67.
C16H12BrN3O: C, 56.16; H, 3.53; N, 12.28, found: C, 56.06; H,
3.57; N, 12.26.
Synthesis of dihydroamidinoquinoxaline N-oxide methiodides
2. General procedure.
A mixture of the corresponding compound 1 (1 mmol) and
methyl iodide (3 mmol) in anhydrous methylene chloride
(10 mL) were refluxed protected from moisture. The reaction was
monitored by TLC (silica gel, chloroform–methanol 9:1) until no
further conversion to compounds 2 was evidenced. The solution
was evaporated in vacuo and the crude products were purified by
crystallization.
Yields and analytical data of compounds 2a,b are as follows.
5-(2-Methylphenyl)-4-methyl-2,3-dihydro-1H-pyrimido[1,2-a]-
quinoxalinium iodide 6-oxide 2a was obtained as a yellow solid
(52%), Mp 251–253 °C (isopropanol). MS (EI), m/z 291 (M+.-ICH3)
[18,19]. Anal. Calcd. for C19H20IN3O: C, 52.67; H, 4.65; N, 9.70,
found: C, 52.56; H, 4.69; N, 9.66.
N-(2-Methylphenyl)acetyl-N0-(2-nitrophenyl)ethylenediamine
(3d) was obtained as a yellow solid (100%), Mp 110–112 °C (etha-
nol/water). 1H NMR: d = 8.16 (1H, dd, J = 8.7 and 1.7 Hz), 8.04 (1H,
bs, ex), 7.41–7.47 (1H, m), 7.10–7.24 (4H, m), 6.94 (1H, d,
J = 8.7 Hz), 6.67 (1H, ddd, J = 8.7, 6.9 and 1.3 Hz), 5.60 (1H, bs,
ex), 3.60 (2H, s), 3.46–3.48 (4H, m), 2.24 (3H, s). MS (EI), m/z 329
(M+.). Anal. Calcd. for C18H23N3O3: C, 65.63; H, 7.04; N, 12.76,
found: C, 65.52; H, 7.07; N, 12.73.
N-(2-Bromophenyl)acetyl-N0-(2-nitrophenyl)ethylenediamine
(3e) was obtained as a yellow solid (86%), Mp 134–136 °C (ethanol/
water). 1H NMR: d = 8.18 (1H, dd, J = 8.5 and 1.5 Hz), 8.09 (1H, bs,
ex), 7,59 (1H, dd, J = 8.0 and 1.0), 7.44–7.47 (1H, m), 7.30–7.35
(2H, m), 7.18 (1H, ddd, J = 8.0, 6.9 and 2.4), 6.97 (1H, dd, J = 8.7
and 1.2), 6.69 (1H, ddd, J = 8.5, 7.1 and 1.2), 5.83 (1H, bs, ex),
3.75 (2H, s), 3.51–3.55 (4H, m). MS (EI), m/z 377 (M+.). Anal. Calcd.
for C16H16BrN3O3: C, 50.81; H, 4.26; N, 11.11, found: C, 50.73; H,
4.29; N, 11.09.
4-(2-Methylphenyl)-3-methyl-1,2-dihydroimidazo[1,2-a]quin-
oxalinium iodide 5-oxide 2b was obtained as a yellow solid (64%),
Mp > 270 °C (isopropanol). MS (EI), m/z 277 (M+.-ICH3). Anal. Calcd.
for C18H18IN3O: C, 51.57; H, 4.33; N, 10.02, found: C, 51.49; H, 4.36;
N, 9.99.
2.2. Spectra
1H and 13C NMR spectra were recorded on a Bruker Avance II
500 spectrometer operating at 500.13 and 125.77 MHz, respec-
tively. Spectra were acquired from samples as solutions at room
temperature in 5 mm tubes. Unless otherwise indicated, deutero-
chloroform was used as the solvent. The standard concentration
of the samples was 10 and 40 mg/mL for 1H and 13C NMR spectra,
respectively. Chemical shifts (d) are reported in ppm, referenced to
TMS as an internal standard. Coupling constants (J) are reported in
Hz. Multiplicities are quoted as singlet (s), doublet (d), double dou-
blet (dd), doublet of doublet of doublets (ddd), triplet (t), double
triplet (dt), quartet (q) and multiplet (m). Phase-sensitive NOESY,
HSQC and HMBC spectra were recorded on a Bruker Avance II
500 spectrometer.
Synthesis of dihydroamidinoquinoxaline N-oxides 1. General
procedure.
A mixture of the aminoamide 3 (0.5 g) and PPE (10 mL) was re-
acted for 0.5–2 min in a microwave oven (Sanyo EM-D2031)
adapted for reflux heating, alternating 10 s of irradiation at
280 Watt and 10 s without irradiation. After reaching ambient
temperature, the resulting solution was extracted with water
(5 ꢀ 10 mL). The aqueous phases were pooled, filtered and made
alkaline with 10% aqueous NaOH. The mixture was extracted with
chloroform (3 ꢀ 20 mL). The organic phases were washed with
water, dried over sodium sulphate and filtered. The chloroformic
solution was left at r.t. until no further conversion to compounds
1 was evidenced by TLC (silica gel, CHCl3–methanol 9:1). The sol-
vent was then removed in vacuo and the crude product was puri-
fied by column chromatography (silica gel, CHCl3–methanol
10:0 ? 9:1). Yields and analytical data of compounds 1a–d are as
follows.
2.3. Theoretical calculations
Input geometries for compounds 1a,b were preoptimized with
the semiempirical method AM1. The structure/s thus obtained
were then optimized with the HF/6-31Gꢁꢁ method [20]. The result-
ing minima were subjected to frequency calculations with non-
imaginary frequencies obtained.
5-(2-Methylphenyl)-2,3-dihydro-1H-pyrimido[1,2-a]quinoxa-
line 6-oxide 1a was obtained as a yellow solid (53%), Mp 198–
200 °C (hexane/ethyl acetate). MS (EI), m/z 291 (M+.). Anal. Calcd.
for C18H17N3O: C, 74.20; H, 5.88; N, 14.42, found: C, 74.05; H,
5.93; N, 14.39.
3. Results and discussion
5-(2-Chlorophenyl)-2,3-dihydro-1H-pyrimido[1,2-a]quinoxa-
line 6-oxide 1b was obtained as a yellow solid (51%), Mp 170–
172 °C (hexane/ethyl acetate). MS (EI), m/z 311 (M+.). Anal. Calcd.
for C17H14ClN3O: C, 65.49; H, 4.53; N, 13.48, found: C, 65.38; H,
4.55; N, 13.46.
The compounds described in this work are shown in Fig. 1. The
synthetic procedure for compounds 1, 2 is depicted in Scheme 1.
The precursor N-(2-nitrophenyl)-N0-arylacetyl di (or tri) methylen-
5-(2-Bromophenyl)-2,3-dihydro-1H-pyrimido[1,2-a]quinoxa-
line 6-oxide 1c was obtained as a yellow solid (53%), Mp 158–
160 °C (hexane/ethyl acetate). MS (EI), m/z 355 (M+.). Anal. Calcd.
for C17H14BrN3O: C, 57.32; H, 3.96; N, 11.80, found: C, 57.23; H,
3.98; N, 11.78.
4-(2-Methylphenyl)-1,2-dihydroimidazo[1,2-a]quinoxaline 5-
oxide 1d was obtained as a yellow solid (52%), Mp 165–167 °C
(hexane/ethyl acetate). MS (EI), m/z 277 (M+.). Anal. Calcd. for
C
17H15N3O: C, 73.63; H, 5.45 N, 15.15, found: C, 73.49; H, 5.50; N,
15.15.
4-(2-Bromophenyl)-1,2-dihydroimidazo[1,2-a]quinoxaline 5-
oxide 1e was obtained as a yellow solid (51%), Mp 179–180 °C
(hexane/ethyl acetate). MS (EI), m/z 341 (M+.). Anal. Calcd. for
Fig. 1. Amidinoquinoxalines 1a–d and methiodides 2a,b.